Prev Arrow Stocks

Centene Corporation ($CNC) Stock Forecast: Down 40.1% Today

Morpher AI identified a bearish signal. The stock price may continue to fall based on the momentum of the negative news.

What is Centene Corporation?

Centene Corporation (CNC) is a healthcare company that provides a range of services, including Medicaid and Medicare programs, individual and family health insurance, among others. The company has operations in the United States and internationally.

Why is Centene Corporation going down?

CNC stock is down 40.1% on Jul 2, 2025 19:41

  • CNC witnessed a significant decline in its stock value today for the following reasons:
  • The company eliminated its 2025 guidance due to a $1.8 billion risk adjustment shortfall, resulting in decreased investor trust.
  • Sluggish growth in the Marketplace sector also contributed to the prevalent negative outlook on CNC.
  • Downgrades by analysts and the withdrawal of guidance further weighed down on CNC's stock price.
  • The initial analysis of marketplace data by an independent actuarial firm additionally impacted the sharp drop in CNC's shares.

CNC Price Chart

CNC Technical Analysis

CNC News

Centene Pulls 2025 Guidance as Marketplace Growth Falters

CNC pulls its 2025 forecast after a $1.8B risk adjustment shortfall. Also, weak Marketplace growth shakes investor confidence.

https://www.zacks.com/stock/news/2560842/centene-pulls-2025-guidance-as-marketplace-growth-falters

0 Missing News Article Image Centene Pulls 2025 Guidance as Marketplace Growth Falters

Why Is Oscar Health Stock Falling Wednesday - Oscar Health ( NYSE:OSCR )

Centene cut its 2025 risk adjustment forecast by $1.8 billion, impacting EPS by an estimated $2.75. Oscar Health Q1 revenue rose 42% to $3B, beating the $2.86 billion consensus. Market-moving news hits Benzinga Pro first-get a 30-minute edge and save 60% this 4th of July. Oscar Health, Inc.

https://www.benzinga.com/trading-ideas/movers/25/07/46222916/centenes-guidance-withdrawal-spooks-sector-oscar-health-stock-falls

1 Missing News Article Image Why Is Oscar Health Stock Falling Wednesday - Oscar Health  ( NYSE:OSCR )

This Centene Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Arcos Dorados Holdings ( NYSE:ARCO ) , Aptiv ( NYSE:APTV )

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Wolfe Research analyst Emmanuel Rosner downgraded the rating for Aptiv PLC APTV from ...

https://www.benzinga.com/analyst-stock-ratings/downgrades/25/07/46217926/this-centene-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-wednesda

2 News Article Image This Centene Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Arcos Dorados Holdings  ( NYSE:ARCO ) , Aptiv  ( NYSE:APTV )

Centene, BrightView Holdings, ArriVent BioPharma And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - BrightView Hldgs ( NYSE:BV ) , ArriVent BioPharma ( NASDAQ:AVBP )

U.S. stock futures were higher this morning, with the Dow futures gaining around 0.2% on Wednesday. Shares of Centene Corporation CNC fell sharply in today's pre-market trading after the health care company withdrew its guidance for 2025.

https://www.benzinga.com/trading-ideas/movers/25/07/46217859/centene-brightview-holdings-arrivent-biopharma-and-other-big-stocks-moving-lower-in-wednesda

3 News Article Image Centene, BrightView Holdings, ArriVent BioPharma And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - BrightView Hldgs  ( NYSE:BV ) , ArriVent BioPharma  ( NASDAQ:AVBP )

Centene Withdraws 2025 Guidance, Shares Dive - Centene ( NYSE:CNC )

Centene withdraws its 2025 earnings guidance and all underlying guidance elements. The withdrawal follows a preliminary interpretation of marketplace data from independent actuarial firm Wakely. Market-moving news hits Benzinga Pro first-get a 30-minute edge and save 60% this 4th of July.

https://www.benzinga.com/markets/guidance/25/07/46209736/centene-withdraws-2025-guidance-shares-dive

4 News Article Image Centene Withdraws 2025 Guidance, Shares Dive - Centene  ( NYSE:CNC )

Centene Corporation Price History

25.03.2025 - CNC Stock was down 5.3%

  • Despite Centene beating Q1 earnings and revenue estimates, the stock still experienced a bearish movement, indicating that the market may have had higher expectations.
  • The reaffirmation of annual profit guidance by Centene was not enough to offset the negative market sentiment impacting the stock price.
  • Analyst estimates for Centene's Q1 earnings and performance may have played a role in influencing investor sentiment and contributing to the bearish movement.
  • The overall market conditions or external factors could have overshadowed Centene's positive earnings report, leading to the bearish movement in the stock price.

25.03.2025 - CNC Stock was down 5.7%

  • Despite reporting better than expected Q1 earnings and confirming its annual profit guidance, Centene (CNC) witnessed a bearish trend.
  • Market concerns may have arisen from a decrease in total membership despite notable growth in Marketplace and PDP memberships.
  • Investors' focus on factors beyond financial performance could have contributed to the stock sell-off.
  • High expectations from Wall Street analysts regarding Centene's (CNC) future earnings growth might have led to disappointment among investors, triggering the bearish movement.

02.06.2025 - CNC Stock was down 32.8%

  • Following the withdrawal of its 2025 guidance, Centene's stock experienced a notable decline, prompting uncertainty among investors and increased selling activity.
  • The negative sentiment towards the stock was exacerbated by analysts lowering their ratings on Centene.
  • Technical analysis suggests that Centene's stock may currently be oversold, hinting at a potential reversal in trend in the near term.
  • The interplay of withdrawn guidance, analyst downgrades, and technical indicators likely contributed to the bearish trend in Centene's stock price for the day.

02.06.2025 - CNC Stock was down 40.1%

  • CNC witnessed a significant decline in its stock value today for the following reasons:
  • The company eliminated its 2025 guidance due to a $1.8 billion risk adjustment shortfall, resulting in decreased investor trust.
  • Sluggish growth in the Marketplace sector also contributed to the prevalent negative outlook on CNC.
  • Downgrades by analysts and the withdrawal of guidance further weighed down on CNC's stock price.
  • The initial analysis of marketplace data by an independent actuarial firm additionally impacted the sharp drop in CNC's shares.

02.06.2025 - CNC Stock was down 39.2%

  • CNC's stock price plummeted following the withdrawal of its 2025 earnings guidance, which had a negative impact on investor confidence.
  • The reduction of $1.8 billion in Centene's 2025 risk adjustment forecast and the consequent projected impact of $2.75 on EPS were key factors driving the bearish movement.
  • Despite Oscar Health's robust revenue growth in Q1, the overshadowing effect of Centene's guidance withdrawal on industry sentiment contributed to CNC's bearish performance.
  • The technical oversold status of CNC, coupled with indications from analysts suggesting a potential trend reversal, indicate a possible shift in CNC's stock performance on the horizon.

03.03.2025 - CNC Stock was up 5.5%

  • CNC's partnership expansion with HMHB Hawaii for maternal care highlights a strategic investment in supporting mothers and babies, underscoring a dedication to enhancing healthcare services.
  • Investors may view this move positively, seeing CNC's focus on improving healthcare outcomes as a potential catalyst for market share growth in the maternal care sector.
  • The bullish movement in CNC's stock today could be linked to this development, with investors likely interpreting the partnership as a favorable step that may drive future growth and profitability for the company.

12.04.2025 - CNC Stock was down 2.1%

  • CNC's bearish movement today could be attributed to profit-taking by investors after a recent bullish run.
  • The comparison with Adaptive Biotechnologies (ADPT) might have highlighted CNC's underperformance in the medical sector, leading to a sell-off.
  • Investors may have concerns about CNC's future growth prospects or operational challenges, prompting the bearish sentiment.
  • Overall, CNC's downward movement today could be a combination of sector-specific factors and profit booking, contributing to the bearish trend.

23.04.2025 - CNC Stock was down 5.1%

  • Today, despite positive long-term performance, Centene's stock experienced a strong bearish movement. This could be attributed to:
  • Profit-taking by investors after a prolonged period of outperformance.
  • Market concerns about potential regulatory changes impacting government-sponsored healthcare programs.
  • General market volatility leading to a broader sell-off in the healthcare sector.
  • Contradiction between the long-term growth prospects and short-term market sentiment driving the bearish movement.

08.03.2025 - CNC Stock was up 5.9%

  • Analyst upgrades and positive outlook: Top Wall Street analysts have upgraded their outlook on Centene, likely contributing to the stock's bullish movement.
  • Positive earnings estimate revisions: Recent trend in earnings estimate revisions for Centene indicates potential strength in the stock, boosting investor confidence and buying activity.
  • Expectations of beating earnings estimates: Backed by a history of impressive earnings surprises and favorable conditions for exceeding estimates in the next quarterly report, investors are optimistic about Centene's future performance, leading to a rise in the stock price.

17.03.2025 - CNC Stock was down 5.5%

  • Today's bearish movement in Centene's stock may be due to investors taking profits after a period of growth.
  • Positive long-term developments such as SilverSummit's expansion in Nevada and the Medicaid contract award could be overshadowed by short-term market uncertainties.
  • The stock price downturn could be a result of investors reevaluating Centene's valuation following recent news.
  • The bearish movement may be a mix of profit-taking, short-term market reactions, and reassessment of the company's valuation amidst recent positive developments.

16.04.2025 - CNC Stock was up 5.0%

  • Centene Corporation (CNC) experienced a strong bullish movement today.
  • Mentioning "3 Stocks to Buy Following Robust Results" may have included CNC as one of the recommended stocks to buy after posting stellar quarterly results.
  • The raised outlooks of companies in the healthcare sector, including Centene, may have contributed to the bullish momentum in CNC's stock price.
  • Investors are likely optimistic about Centene's future performance and growth prospects, leading to increased buying interest and driving the stock higher.

23.03.2025 - CNC Stock was up 5.0%

  • CNC stock displayed a significant bullish trend today, possibly influenced by positive market sentiment and the anticipation surrounding the upcoming Q1 earnings.
  • Analysts exhibit optimism regarding Centene's performance for the quarter ending March 2025, forecasting potential earnings growth that surpasses revenue and EPS estimates.
  • The favorable analyst predictions and expectations of an earnings beat in the forthcoming report could have spurred the bullish movement in CNC stock.
  • Investors seem to be responding positively to Centene's growth potential and strong fundamentals, resulting in heightened buying activity and an increase in the stock price.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.